Addressing market access challenges as CGTs expand to larger patient populations

Cell and gene therapies (CGTs) represent a paradigm shift in the treatment of numerous complex diseases, offering potentially curative options that were once unimaginable. However, as these transformative therapies gain traction, the U.S. market faces a multitude of market access challenges that must be addressed to realize their full potential. For your commercialization strategy to succeed, you should consider the strategies in this article.